Acurx Pharmaceuticals, Inc. (ACXP) financial statements and ratios from SEC XBRL: revenue $125445.00 (TTM), net margin -6350.6%, revenue growth 523.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $125445.00 |
| Net Margin | -6350.6% |
| Revenue Growth (YoY) | 523.4% |
| EPS Growth (YoY) | 511.5% |
| Price / Book | 0.78 |
| Price / Sales | 40.01 |
| Sector P/E (Healthcare) | 21.7 |
ACXP overview · ACXP earnings · ACXP KPIs · ACXP investor relations · ACXP ownership · ACXP peers · ACXP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.